United States · FDA National Drug Code directory

Lisdexamfetamine Dimesylate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0054-0372_ccd9e87c-bd03-4fe0-8129-41c1ced49c8d
Product NDC: 0054-0372
Form: CAPSULE
Composition / generic term: lisdexamfetamine dimesylate
Labeler: Hikma Pharmaceuticals USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20230825
Source listing expiry: 20271231

Source-listed ingredients

LISDEXAMFETAMINE DIMESYLATE — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 CAPSULE in 1 BOTTLE (0054-0372-25) · 0054-0372-25

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →